UroGen Pharma Ltd. — Director's Dealing 2017

Jul 20, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2017-05-09

Reporting Person: ProQuest Investments IV, L.P. (10% Owner)
Reporting Person: ProQuest Associates IV LLC (10% Owner)
Reporting Person: Moorin Jay (10% Owner)
Reporting Person: SCHREIBER ALAIN (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares, par value NIS 0.01 per share	1451329	Direct

Footnotes

F1: The securities are directly held by ProQuest Investments IV, L.P. and indirectly held by ProQuest Associates IV, LLC, the General Partner of ProQuest Investments IV, L.P. The individual managing members of ProQuest Associates IV, LLC are Jay Moorin and Alain Schreiber, M.D., who may be deemed to have shared voting and investment and dispositive power with respect to these shares. Each individual managing member disclaims beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.